1. CDK6 inhibits de novo lipogenesis in white adipose tissues but not in the liver
- Author
-
Alexander J. Hu, Wei Li, Calvin Dinh, Yongzhao Zhang, Jamie K. Hu, Stefano G. Daniele, Xiaoli Hou, Zixuan Yang, John M. Asara, Guo-fu Hu, Stephen R. Farmer, and Miaofen G. Hu
- Subjects
Science - Abstract
Abstract Increased de novo lipogenesis (DNL) in white adipose tissue is associated with insulin sensitivity. Under both Normal-Chow-Diet and High-Fat-Diet, mice expressing a kinase inactive Cyclin-dependent kinase 6 (Cdk6) allele (K43M) display an increase in DNL in visceral white adipose tissues (VAT) as compared to wild type mice (WT), accompanied by markedly increased lipogenic transcriptional factor Carbohydrate-responsive element-binding proteins (CHREBP) and lipogenic enzymes in VAT but not in the liver. Treatment of WT mice under HFD with a CDK6 inhibitor recapitulates the phenotypes observed in K43M mice. Mechanistically, CDK6 phosphorylates AMP-activated protein kinase, leading to phosphorylation and inactivation of acetyl-CoA carboxylase, a key enzyme in DNL. CDK6 also phosphorylates CHREBP thus preventing its entry into the nucleus. Ablation of runt related transcription factor 1 in K43M mature adipocytes reverses most of the phenotypes observed in K43M mice. These results demonstrate a role of CDK6 in DNL and a strategy to alleviate metabolic syndromes.
- Published
- 2024
- Full Text
- View/download PDF